Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
In the latest session, Exelixis Inc (NASDAQ: EXEL) closed at $43.58 down -0.57% from its previous closing price of $43.83. In other words, the price has decreased by -$0.57 from its previous closing price. On the day, 2.49 million shares were traded. EXEL stock price reached its highest trading level at $43.725 during the session, while it also had its lowest trading level at $43.0.
Ratios:
For a deeper understanding of Exelixis Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.82 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 14.98. For the most recent quarter (mrq), Quick Ratio is recorded 3.68 and its Current Ratio is at 3.75. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.08.
Leerink Partners Upgraded its Market Perform to Outperform on October 21, 2025, while the target price for the stock was maintained at $48.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 20 ’25 when Haley Patrick J. bought 10,648 shares for $41.78 per share.
JOHNSON DAVID EDWARD bought 27,532 shares of EXEL for $1,187,235 on Nov 25 ’25. The Director now owns 1,553,262 shares after completing the transaction at $43.12 per share. On Nov 20 ’25, another insider, Haley Patrick J., who serves as the EVP, Commercial of the company, sold 34,187 shares for $41.88 each. As a result, the insider received 1,431,757 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EXEL now has a Market Capitalization of 11731847168 and an Enterprise Value of 10872255488. As of this moment, Exelixis’s Price-to-Earnings (P/E) ratio for their current fiscal year is 18.35, and their Forward P/E ratio for the next fiscal year is 13.51. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.40. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.11 while its Price-to-Book (P/B) ratio in mrq is 5.41. Its current Enterprise Value per Revenue stands at 4.751 whereas that against EBITDA is 12.791.
Stock Price History:
The Beta on a monthly basis for EXEL is 0.40, which has changed by 0.31265056 over the last 52 weeks, in comparison to a change of 0.14778805 over the same period for the S&P500. Over the past 52 weeks, EXEL has reached a high of $49.62, while it has fallen to a 52-week low of $31.90. The 50-Day Moving Average of the stock is 3.45%, while the 200-Day Moving Average is calculated to be 7.93%.
Shares Statistics:
For the past three months, EXEL has traded an average of 2.73M shares per day and 2403940 over the past ten days. A total of 268.10M shares are outstanding, with a floating share count of 259.61M. Insiders hold about 3.17% of the company’s shares, while institutions hold 95.94% stake in the company. Shares short for EXEL as of 1765756800 were 22834554 with a Short Ratio of 8.35, compared to 1763078400 on 20145618. Therefore, it implies a Short% of Shares Outstanding of 22834554 and a Short% of Float of 11.76.
Earnings Estimates
. The current market rating for Exelixis Inc (EXEL) reflects the collective analysis of 13.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is $0.69, with high estimates of $0.82 and low estimates of $0.59.
Analysts are recommending an EPS of between $3.18 and $2.16 for the fiscal current year, implying an average EPS of $2.92. EPS for the following year is $3.28, with 13.0 analysts recommending between $3.91 and $2.55.
Revenue Estimates
A total of 17 analysts believe the company’s revenue will be $609.25M this quarter.It ranges from a high estimate of $631.03M to a low estimate of $530.4M. As of. The current estimate, Exelixis Inc’s year-ago sales were $566.75MFor the next quarter, 17 analysts are estimating revenue of $624.59M. There is a high estimate of $667.6M for the next quarter, whereas the lowest estimate is $593.67M.
A total of 19 analysts have provided revenue estimates for EXEL’s current fiscal year. The highest revenue estimate was $2.35B, while the lowest revenue estimate was $2.3B, resulting in an average revenue estimate of $2.33B. In the same quarter a year ago, actual revenue was $2.17BBased on 19 analysts’ estimates, the company’s revenue will be $2.61B in the next fiscal year. The high estimate is $2.96B and the low estimate is $2.44B.
